Ligand Pharmaceuticals Incorporated
$5.38B- Market cap
- $5.74B
- Debt
- +$374.08M
- Cash
- −$733.52M
Capital structure 94% equity / 6% debt · EV / Revenue 20.06x · EV / EBITDA 33.56x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
LGND · price snapshotP/E 46.95x
$287.82Snapshot Sep 8, 2026, 3:11 PM ET
Implied fair value · at BURL's multiple
$163.7043.1% below market
6.13 LGND Annual EPS×26.70x BURL P/E=$163.70
Market $287.82Implied $163.70
BURL · price snapshotP/E 26.70x
$253.96Snapshot Sep 8, 2026, 3:14 PM ET
Implied fair value · at LGND's multiple
$446.5275.8% above market
9.51 BURL Annual EPS×46.95x LGND P/E=$446.52
Market $253.96Implied $446.52